Skip to main content

Drug Safety

      RT @drdavidliew: Big one from plenary, new option in ANCA-associated vasculitis:
      avacopan (anti-C5a) vs prednisolone in
      4 years 6 months ago
      Big one from plenary, new option in ANCA-associated vasculitis: avacopan (anti-C5a) vs prednisolone in patients receiving CYC/RTX: non-inf at 26w, superior at 52w in the phase III ADVOCATE trial with reduction in steroid toxicity Merkel, Jayne et al OP0011 #EULAR2020 @RheumNow
      RT @DrPetryna: #eular2020 #op0302 Ianalumab (VAY736) dual action BAFFreceptor inhibitor/B cell depletion meets primary e
      4 years 6 months ago
      #eular2020 #op0302 Ianalumab (VAY736) dual action BAFFreceptor inhibitor/B cell depletion meets primary end point in p2b for pSS: EESDAI⬇️1.92 pts over PBO at wk24. Dis not meet 2ry endpoint ESSPRI&FACIT-F. Good side effect profile w/mild inj site reactions mostly @RheumNow https://t.co/9qsfUNho9h
      RT @drdavidliew: You might think that steroid exposure in PMR patients wouldn't lead to new comorbidities.

      These data b
      4 years 6 months ago
      You might think that steroid exposure in PMR patients wouldn't lead to new comorbidities. These data beg to differ. New steroid-related comorbidities ++ across domains vs matched controls in real-world US claims data. We need steroid-sparing in PMR. OP0271 #EULAR2020 @RheumNow https://t.co/mSzWcJSpfV
      RT @drdavidliew: Does TCZ actually fix GCA?
      @nihrheumatology cohort w serial PET/CT q6m:
      FDG uptake (PETVAS) reduces lon
      4 years 6 months ago
      Does TCZ actually fix GCA? @nihrheumatology cohort w serial PET/CT q6m: FDG uptake (PETVAS) reduces longitudinally over 2y but does not normalise, w rebound on TCZ cessation Ongoing reductions in year 2? GCA doesn't sleep. @KQuinnRheum @petercgrayson OP0144 #EULAR2020 @RheumNow https://t.co/aczQbONcNc
      RT @Janetbirdope: Our study shows that HCQ retinopathy virtually never occurs in first 5 yrs, SLE has more risk than oth
      4 years 6 months ago
      Our study shows that HCQ retinopathy virtually never occurs in first 5 yrs, SLE has more risk than other diseases such as RA and chloroquine has a far higher risk of retinal toxicity OP0333 #EULAR2020 @RheumNow @CRASCRRheum @earlyarthritis https://t.co/ZzRy3po4yw
      RT @KDAO2011: #EULAR2020 OP0167 Results are finally in!!
      MMF can be safely w/drawn in quiescent SLE: prospect RCT (nonbl
      4 years 6 months ago
      #EULAR2020 OP0167 Results are finally in!! MMF can be safely w/drawn in quiescent SLE: prospect RCT (nonblinded) 102 pts. MMF tapered over 12 weeks, f/u 60 weeks; no sig diff for flares in pts who stopped MMF vs. maintained; pts who cont MMF had ⬆️ minor infections. @rheumnow https://t.co/bOnuEBLis9
      When starting IV Pegloticase in #Gout, Do you start a DMARD too? #EULAR2020
      4 years 6 months ago

      When starting IV Pegloticase in #Gout, Do you start a DMARD too? #EULAR2020

      In difficult times, it's reassuring to reflect on the similarities that bring us together. In the case of the EULAR and ACR COVID19 guidelines as discussed at #EULAR2020 by Drs. Mikuls and Landewe,…
      NEJM has reported that the use of hydroxychloroquine did not prevent symptomatic COVID-19 infection when used within 4 days after SARS-CoV-2 exposure. Currently for persons who are COVID…
      ×